Food recall: Salads, sandwiches, wraps sold across New Zealand may have listeria – Newshub
Not all products are affected, however.
Debenhams pension scandal: MPs demand answers as retirees face 10% cut
The chairmen of two parliamentary committees say private equity firms accused of asset stripping Debenhams should be quizzed…
MARKET REPORT: Crypto craze cools as Bitcoin crashes below $30,000
Bitcoin slid to $29,785 as it failed to recover from a sell-off that struck most financial markets on Monday. The dip means bitcoin’s…
Best THC Gummies: Top 5 Brands for Cannabis Edibles [2021]
We have identified the best THC gummies on the market that not only undergo third-party testing but also offer a variety of benefits…
NewsWatch: After worst quarter yet for new subscribers, Netflix says rebound won’t be as fast as Wall Street expects
Netflix Inc. shares fell in after-hours trading Tuesday, after the streaming service revealed its worst quarter yet for adding…
SmartFinancial Announces Results for the Second Quarter 2021
KNOXVILLE, Tenn., July 20, 2021 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial” or the “Company”; NASDAQ: SMBK), today…
Brookfield Property Partners Obtains Final Court Approval for the Privatization Transaction and Brookfield Property REIT Announces Intention to Redeem Its 6.375% Series A Cumulative Redeemable Preferred Stock
BROOKFIELD NEWS, July 20, 2021 (GLOBE NEWSWIRE) — Brookfield Asset Management Inc. (“BAM”) (NYSE: BAM; TSX: BAM.A) and Brookfield…
Netflix will press start on video game ‘expansion’ with games for smartphones, tablets
The Netflix earnings letter to shareholders said mobile games will come to its streaming service. Subscriber growth is slowing;…
Building A Bear-Proof Portfolio: Investing Safely Up As The Fear & Greed Index Approaches Early 2020 Levels. – Benzinga
Market Fear Gauge Approaches 2020 LevelsAs ZeroHedge reported on Monday, the Fear & Greed gauge has approached early 2020 levels. …
Here’s Why Cassava Sciences Is Up 1,152% in the First Half of 2021
This small-cap biotech has shot up in value as the company’s Alzheimer’s drug makes it way through clinical trials.